Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Computed Tomography01:10

Computed Tomography

7.6K
Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.6K
Positron Emission Tomography01:29

Positron Emission Tomography

6.6K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.6K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

324
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[<sup>18</sup>F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418.

EJNMMI research·2026
Same author

Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.

Annals of neurology·2026
Same author

Alzheimer's Imaging Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

JAMA psychiatry·2025
Same author

Interplay between astrocyte reactivity and APOE ε4 status is associated with accelerated pTau-related tau pathology in Alzheimer's disease.

Molecular neurodegeneration·2025

Related Experiment Video

Updated: Nov 19, 2025

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

13.0K

TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans.

Alex Whittington1, Roger N Gunn2,3,

  • 1Invicro LLC, London, United Kingdom; and alexander.whittington@invicro.co.uk.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|January 31, 2021
PubMed
Summary
This summary is machine-generated.

A new TauIQ algorithm offers superior quantification of tau PET scans, significantly improving longitudinal analysis power and early detection of tau deposition in Alzheimer's disease (AD). This advanced method aids clinical trials investigating novel therapies.

Keywords:
IQ platformcanonical imagesflortaucipirpower in clinical trialsstatistical analysistau PET

More Related Videos

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images
09:21

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images

Published on: February 18, 2015

12.4K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

694

Related Experiment Videos

Last Updated: Nov 19, 2025

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

13.0K
Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images
09:21

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images

Published on: February 18, 2015

12.4K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

694

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Alzheimer's Disease Research

Background:

  • AmyloidIQ, an image-based algorithm, improved amyloid PET scan quantification over traditional SUV ratio (SUVR) methods.
  • Quantifying tau PET scans presents challenges due to complex spatial distribution of tau radiotracers.
  • There is a need for advanced algorithms to accurately measure tau deposition in Alzheimer's Disease (AD).

Purpose of the Study:

  • To develop and validate the TauIQ algorithm for quantitative analysis of tau PET data.
  • To compare the performance of TauIQ against traditional SUVR approaches.
  • To assess TauIQ's utility in cross-sectional, longitudinal, and clinical correlation analyses.

Main Methods:

  • Utilized 18F-flortaucipir PET data from 615 cross-sectional and 149 longitudinal participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
  • Developed canonical tau images using AmyloidIQ to determine temporal disease progression and incorporated them into the TauIQ algorithm.
  • Compared TauIQ performance with SUVR for cross-sectional and longitudinal analyses, and correlation with clinical measures (ADAS-Cog, CDR-SB, MMSE).

Main Results:

  • TauIQ successfully quantified global tau load (TauL) across all 791 analyzed scans.
  • A local tau component was necessary in 31% of scans, increasing with disease severity (22% cognitively normal, 35% MCI, 72% dementia).
  • TauIQ demonstrated superior performance over SUVR in cross-sectional analysis effect sizes and significantly outperformed SUVR in longitudinal analysis power ( >2.2-fold increase).

Conclusions:

  • The TauIQ algorithm provides a superior method for quantifying tau PET data, outperforming SUVR approaches.
  • TauIQ significantly enhances the power of longitudinal analyses and facilitates early detection of tau deposition.
  • TauIQ holds significant value for clinical imaging trials in AD aimed at evaluating therapies that attenuate tau deposition.